Skip to main content Help with accessibility Skip to main navigation

Insulin Aspart

Indication

For the treatment of diabetes mellitus type 1 and 2 in adults
Green (Restricted)

Brand:

Fiasp®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Endocrine system

Background

Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin.
Insulin Aspart (Fiasp®) is recommended for the treatment of diabetes mellitus in adults who are suitable for NovoRapid® and their diabetes cannot be adequately managed with alternative formulary choices and at least one of the following applies:
  • where the prescriber believes a faster onset of action would be beneficial to the patient
  • where a patient requires ‘tight’ control of blood sugar levels
  • where a patient has rapid post meal increase in blood sugar levels

Recommendation

LSCMMG Recommendation:

Green (Restricted)

Reason for decision:

Suitable for initiation in primary care in line with restrictions

Decisions of Lancashire local decision making groups

Green
Green
Amber 0
Green
Green
Amber 0
Green
Amber 0
What do the colours mean?

Last Updated: 01 - Sep - 2017